111 related articles for article (PubMed ID: 28453490)
1. Plasma Amyloid-β and Alzheimer's Disease-Related Changes in Late-Life Depression.
Yamazaki C; Tamaoki T; Nunomura A; Tamai K; Yasuda K; Motohashi N
J Alzheimers Dis; 2017; 58(2):349-354. PubMed ID: 28453490
[TBL] [Abstract][Full Text] [Related]
2. Plasma amyloid-β levels in drug-resistant bipolar depressed patients receiving electroconvulsive therapy.
Piccinni A; Veltri A; Vizzaccaro C; Catena Dell'Osso M; Medda P; Domenici L; Vanelli F; Cecchini M; Franceschini C; Conversano C; Marazziti D; Dell'Osso L
Neuropsychobiology; 2013; 67(4):185-91. PubMed ID: 23635805
[TBL] [Abstract][Full Text] [Related]
3. Elevation of Plasma Amyloid-β Level is More Significant in Early Stage of Cognitive Impairment: A Population-Based Cross-Sectional Study.
Wang J; Qiao F; Shang S; Li P; Chen C; Dang L; Jiang Y; Huo K; Deng M; Wang J; Qu Q
J Alzheimers Dis; 2018; 64(1):61-69. PubMed ID: 29865072
[TBL] [Abstract][Full Text] [Related]
4. The relationship of plasma Aβ levels to dementia in aging individuals with mild cognitive impairment.
Fei M; Jianghua W; Rujuan M; Wei Z; Qian W
J Neurol Sci; 2011 Jun; 305(1-2):92-6. PubMed ID: 21440911
[TBL] [Abstract][Full Text] [Related]
5. Reduction of Amyloid-β Plasma Levels by Hemodialysis: An Anti-Amyloid Treatment Strategy?
Tholen S; Schmaderer C; Chmielewski S; Förstl H; Heemann U; Baumann M; Steubl D; Grimmer T
J Alzheimers Dis; 2016; 50(3):791-6. PubMed ID: 26682683
[TBL] [Abstract][Full Text] [Related]
6. Chemically treated plasma Aβ is a potential blood-based biomarker for screening cerebral amyloid deposition.
Park JC; Han SH; Cho HJ; Byun MS; Yi D; Choe YM; Kang S; Jung ES; Won SJ; Kim EH; Kim YK; Lee DY; Mook-Jung I
Alzheimers Res Ther; 2017 Mar; 9(1):20. PubMed ID: 28330509
[TBL] [Abstract][Full Text] [Related]
7. Electroconvulsive therapy response in late-life depression unaffected by age-related brain changes.
Bouckaert F; Emsell L; Vansteelandt K; De Winter FL; Van den Stock J; Obbels J; Dols A; Stek M; Adamczuk K; Sunaert S; Van Laere K; Sienaert P; Vandenbulcke M
J Affect Disord; 2019 May; 251():114-120. PubMed ID: 30921594
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneity of elderly depression: increased risk of Alzheimer's disease and Aβ protein metabolism.
Namekawa Y; Baba H; Maeshima H; Nakano Y; Satomura E; Takebayashi N; Nomoto H; Suzuki T; Arai H
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jun; 43():203-8. PubMed ID: 23276885
[TBL] [Abstract][Full Text] [Related]
9. Increased protein-conjugated acrolein and amyloid-β40/42 ratio in plasma of patients with mild cognitive impairment and Alzheimer's disease.
Waragai M; Yoshida M; Mizoi M; Saiki R; Kashiwagi K; Takagi K; Arai H; Tashiro J; Hashimoto M; Iwai N; Uemura K; Igarashi K
J Alzheimers Dis; 2012; 32(1):33-41. PubMed ID: 22751175
[TBL] [Abstract][Full Text] [Related]
10. Ten-year change in plasma amyloid beta levels and late-life cognitive decline.
Okereke OI; Xia W; Selkoe DJ; Grodstein F
Arch Neurol; 2009 Oct; 66(10):1247-53. PubMed ID: 19822780
[TBL] [Abstract][Full Text] [Related]
11. Plasma and cerebrospinal fluid amyloid-β levels in late-life depression: A systematic review and meta-analysis.
Nascimento KK; Silva KP; Malloy-Diniz LF; Butters MA; Diniz BS
J Psychiatr Res; 2015 Oct; 69():35-41. PubMed ID: 26343592
[TBL] [Abstract][Full Text] [Related]
12. Elevation of the Plasma Aβ40/Aβ42 Ratio as a Diagnostic Marker of Sporadic Early-Onset Alzheimer's Disease.
Kim HJ; Park KW; Kim TE; Im JY; Shin HS; Kim S; Lee DH; Ye BS; Kim JH; Kim EJ; Park KH; Han HJ; Jeong JH; Choi SH; Park SA
J Alzheimers Dis; 2015; 48(4):1043-50. PubMed ID: 26444752
[TBL] [Abstract][Full Text] [Related]
13. Elevation in plasma Abeta42 in geriatric depression: a pilot study.
Pomara N; Doraiswamy PM; Willoughby LM; Roth AE; Mulsant BH; Sidtis JJ; Mehta PD; Reynolds CF; Pollock BG
Neurochem Res; 2006 Mar; 31(3):341-9. PubMed ID: 16583267
[TBL] [Abstract][Full Text] [Related]
14. Plasma Amyloid-β Peptides in Type 2 Diabetes: A Matched Case-Control Study.
Peters KE; Davis WA; Taddei K; Martins RN; Masters CL; Davis TM; Bruce DG
J Alzheimers Dis; 2017; 56(3):1127-1133. PubMed ID: 28106562
[TBL] [Abstract][Full Text] [Related]
15. Distinction between mild cognitive impairment and Alzheimer's disease by CSF amyloid β40 and β42, and protein-conjugated acrolein.
Mizoi M; Yoshida M; Saiki R; Waragai M; Uemura K; Akatsu H; Kashiwagi K; Igarashi K
Clin Chim Acta; 2014 Mar; 430():150-5. PubMed ID: 24508996
[TBL] [Abstract][Full Text] [Related]
16. Plasma amyloid beta-42 independently predicts both late-onset depression and Alzheimer disease.
Blasko I; Kemmler G; Jungwirth S; Wichart I; Krampla W; Weissgram S; Jellinger K; Tragl KH; Fischer P
Am J Geriatr Psychiatry; 2010 Nov; 18(11):973-82. PubMed ID: 20808106
[TBL] [Abstract][Full Text] [Related]
17. Plasma levels of Interleukin 18 but not amyloid-β or Tau are elevated in female depressive patients.
Liu FR; Yang LY; Zheng HF; Zhou Y; Chen BB; Xu H; Zhang YW; Shen DY
Compr Psychiatry; 2020 Feb; 97():152159. PubMed ID: 31931428
[TBL] [Abstract][Full Text] [Related]
18. Blood amyloid beta levels in healthy, mild cognitive impairment and Alzheimer's disease individuals: replication of diastolic blood pressure correlations and analysis of critical covariates.
Ruiz A; Pesini P; Espinosa A; Pérez-Grijalba V; Valero S; Sotolongo-Grau O; Alegret M; Monleón I; Lafuente A; Buendía M; Ibarria M; Ruiz S; Hernández I; San José I; Tárraga L; Boada M; Sarasa M
PLoS One; 2013; 8(11):e81334. PubMed ID: 24312290
[TBL] [Abstract][Full Text] [Related]
19. Changes in plasma amyloid beta in a longitudinal study of aging and Alzheimer's disease.
Rembach A; Faux NG; Watt AD; Pertile KK; Rumble RL; Trounson BO; Fowler CJ; Roberts BR; Perez KA; Li QX; Laws SM; Taddei K; Rainey-Smith S; Robertson JS; Vandijck M; Vanderstichele H; Barnham KJ; Ellis KA; Szoeke C; Macaulay L; Rowe CC; Villemagne VL; Ames D; Martins RN; Bush AI; Masters CL;
Alzheimers Dement; 2014 Jan; 10(1):53-61. PubMed ID: 23491263
[TBL] [Abstract][Full Text] [Related]
20. Amyloid imaging with [(18)F]florbetapir in geriatric depression: early-onset versus late-onset.
Tateno A; Sakayori T; Higuchi M; Suhara T; Ishihara K; Kumita S; Suzuki H; Okubo Y
Int J Geriatr Psychiatry; 2015 Jul; 30(7):720-8. PubMed ID: 25335941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
